Oxyon Pharmaceuticals Private Limited
About Oxyon Pharmaceuticals Private Limited
Data last updated:
Oxyon Pharmaceuticals Private Limited is a private limited company based in Burdwan, West Bengal, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 16 August 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U74999WB2018PTC227395. Its GSTIN is 19AACCO7609Q1ZP (West Bengal).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹6 Lakh. It is led by directors Abdul Kadir and Mobarock Haque.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bahir Sarbamangala Para, Burdwan, West Bengal, India – 713101.
As per the financials filed for FY 2025, the company reported a revenue of ₹27.79 Lakh, a growth of 51% compared to the previous year. For the same year it recorded a net profit of ₹28,670 (net margin 1%) and EBITDA of ₹38,740 (EBITDA margin 1.4%). Revenue has grown at a compounded annual rate (CAGR) of 74% over three years and 79% over five years.
As per MCA filings, the company has open charges of ₹7.87 Lakh on record.
Company details
Contact details
Oxyon Pharmaceuticals Private Limited's registered office is in Burdwan, West Bengal. Its e-mail address is in the company report.
- Email
- Registered AddressBahir Sarbamangala Para, Burdwan, West Bengal, India – 713101
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Oxyon Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Oxyon Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Oxyon Pharmaceuticals Private Limited, buy the company report.
Financials of Oxyon Pharmaceuticals Private Limited
FY 2025 filings availableOxyon Pharmaceuticals Private Limited reported revenue of ₹27.79 Lakh (up 51% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 79% over five years, including 51% growth in the latest year. EBITDA rose 86% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹38,740 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹28,670 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.4% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Oxyon Pharmaceuticals Private Limited, buy the company report.
Board of directors of Oxyon Pharmaceuticals Private Limited
Oxyon Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Abdul Kadir | Director | 16 Aug 2018 | 8 Years 2 Months | Current |
| Mobarock Haque | Director | 16 Aug 2018 | 8 Years 2 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Dec 2025 | 101224755 | Idbi Bank Limited | ₹7.87 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Oxyon Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Oxyon Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Oxyon Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AACCO7609Q1ZP | West Bengal | Active | 10 Jun 2019 |
To see the full GST registrations and return filing status of Oxyon Pharmaceuticals Private Limited, buy the company report.
Recent activity
Oxyon Pharmaceuticals Private Limited has 4 board changes on record since 2018: 2 appointments and 2 cessations. The latest: Ayesha Khatun ceased to be Director on 09 May 2025.
Frequently asked questions
Oxyon Pharmaceuticals is an active private limited company based in Burdwan, West Bengal, India. The company works in other services, within the business services industry. It was incorporated on 16 August 2018 (8+ years old) and is registered under CIN U74999WB2018PTC227395.
Oxyon Pharmaceuticals has 2 current directors:
- Abdul Kadir - Director
- Mobarock Haque - Director
The latest financial statements of Oxyon Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Oxyon Pharmaceuticals is 19AACCO7609Q1ZP, registered in West Bengal.
The CIN (Corporate Identification Number) of Oxyon Pharmaceuticals is U74999WB2018PTC227395. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Oxyon Pharmaceuticals was incorporated on 16 August 2018, making it 8+ years old. It is registered with the Registrar of Companies, Kolkata.
Ayesha Khatun ceased to be Director on 09 May 2025. Mujibar Mallick ceased to be Director on 26 Nov 2018. Abdul Kadir was appointed as Director on 16 Aug 2018. Oxyon Pharmaceuticals has 4 board changes on record in total.
The registered office of Oxyon Pharmaceuticals is at Bahir Sarbamangala Para, Burdwan, West Bengal, India – 713101.
Oxyon Pharmaceuticals operates in the business services industry, in the other services segment.
Oxyon Pharmaceuticals has open charges of ₹7.87 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
